Novavax, Inc.
Vaccine compositions having improved stability and immunogenicity

Last updated:

Abstract:

Disclosed herein are nanoparticles suitable for use in vaccines. The nanoparticles present antigens from pathogens surrounded to and associated with a detergent core resulting in enhanced stability and good immunogenicity. Dosages, formulations, and methods for preparing the vaccines and nanoparticles are also disclosed.

Status:
Grant
Type:

Utility

Filling date:

20 Aug 2019

Issue date:

22 Feb 2022